InterVene key facts
- Developer of medical devices designed to correct deep vein valve failure.
- InterVene’s last known valuation is $24.9M.
- It has raised $37.9M across 4 recorded rounds; the latest was Seed Round ($1.5M) in Feb 2023.
- Notable investors include Correlation Ventures, Stanford University Venture Fund, North Texas Angel Network, American Century Investments, Boston Scientific Ventures — 11 tracked in total.
- InterVene has filed 4 Form Ds with the SEC since 2015, most recently Mar 2023 ($1.5M sold to 6 investors).
- Status: Privately Held (backing).
Who backs InterVene
11+- ·The complete investor list: 11 names
- ·Watch InterVene: the Monday email on marks, rounds and moves
InterVene funding rounds
4 roundsInterVene valuation
InterVene's last known valuation is $24.9 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has InterVene raised?
InterVene has raised $37.9 million in total; 4 of its rounds are on record, from 2015 on. The largest on record was a $5.9 million early-stage round in Mar 2015; the most recent was a $1.5 million seed round in Feb 2023.
InterVene has filed 4 Form Ds with the SEC since 2015, most recently in Mar 2023 ($1.5 million sold to 6 investors).
InterVene investors
11 investors are on record for InterVene, including Correlation Ventures, Stanford University Venture Fund, North Texas Angel Network and American Century Investments. The seed round in Feb 2023 drew 6 investors.
About InterVene
Developer of medical devices designed to correct deep vein valve failure. The company's devices consist of a range of non-implantable, catheter-based therapies to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their hearts, enabling doctors to form new vein valves out of their own vein wall tissue.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2011
- Employees
- 17
- Website
- intervene-med.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
InterVene’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.